Home
Scholarly Works
Fondaparinux versus control (placebo or...
Conference

Fondaparinux versus control (placebo or unfractionated heparin) as an adjunct to thrombolytic therapy in acute myocardial infarction: an OASIS 6 substudy

Authors

Peters RJ; Joyner C; Bassand J-P; Afzal R; Chrolavicius S; Mehta SR; Budaj A; Fox KA; Yusuf S

Volume

114

Pagination

pp. 699-699

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

October 31, 2006

Name of conference

79th Annual Scientific Session of the American-Heart-Association

Conference place

Chicago, IL

Conference start date

November 12, 2006

Conference end date

November 15, 2006

Conference proceedings

CIRCULATION

Issue

18

ISSN

0009-7322

Contact the Experts team